Acadia Healthcare has appointed Mike Fucci to its board, adding an experienced governance and human capital executive to the company’s leadership as it pursues continued expansion in behavioral health services. The director appointment, effective immediately, increases the Acadia Healthcare board to nine members, eight of whom are independent, underscoring the company’s emphasis on independent oversight as it executes strategic growth initiatives.
Fucci joins Acadia Healthcare following a distinguished career at Deloitte U.S., where he served as Executive Chairman from 2015 to 2019 and as Chairman Emeritus until his retirement in September 2020. His tenure at Deloitte spanned decades and encompassed senior roles including Chief Operating Officer of Deloitte Consulting from 2009 to 2015 and leadership of human capital and advisory practices. He has been a member of the Deloitte U.S. Board of Directors since 2013 and joined the Deloitte Global Board in 2015, participating in governance and compensation committees that guided organizational strategy and executive performance evaluation.
Acadia’s board highlighted Fucci’s deep experience in human resource transformation, corporate talent strategies and risk mitigation as directly relevant to the company’s operations and growth plans. Fucci has led efforts at Deloitte in areas such as organizational strategy, leadership succession planning, risk management and executive compensation, and he established and co-chaired the Board Leadership Forum, a coalition that convenes Fortune 500 board chairs and lead directors to discuss governance trends. He also chaired the Deloitte Foundation, which supports education initiatives across the United States.
The selection of Fucci aligns with Acadia Healthcare’s focus on strengthening board governance with directors who bring both sector-specific and cross-industry management expertise. As a leading behavioral healthcare provider, Acadia operates a sizeable network of facilities and continues to navigate demand pressures associated with evolving public health challenges. Industry observers note that Fucci’s background in large-scale organizational transformation and risk oversight could be particularly valuable as the company addresses operational resilience and workforce development.
In remarks accompanying the appointment announcement, Acadia leadership described Fucci as an ideal board member whose principal and practitioner experience at a major professional services firm will complement existing board capabilities and support the company’s objective to deliver long-term value for shareholders. Fucci conveyed that he looks forward to supporting Acadia’s role as a leading provider of behavioral healthcare, particularly during a period of heightened demand driven by the COVID-19 pandemic.
Acadia Healthcare, listed on NASDAQ under the ticker ACHC, reported as of June 30, 2020 that it operated 589 behavioral healthcare facilities with approximately 18,200 beds across 40 U.S. states, the United Kingdom and Puerto Rico. The company delivers services in a range of settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers and outpatient clinics. The addition of Fucci to the board signals Acadia’s continued investment in governance and talent capabilities as it pursues strategic growth in the behavioral health sector.
Click here to learn more about Mike Fucci.